Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

WORX vs CAH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
WORX
SCWorx Corp.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$202K
5Y Perf.-99.9%
CAH
Cardinal Health, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$43.59B
5Y Perf.+252.7%

WORX vs CAH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
WORX logoWORX
CAH logoCAH
IndustryMedical - Healthcare Information ServicesMedical - Distribution
Market Cap$202K$43.59B
Revenue (TTM)$3M$250.55B
Net Income (TTM)$-4M$1.56B
Gross Margin32.0%3.7%
Operating Margin-33.3%0.9%
Forward P/E17.9x
Total Debt$2K$9.35B
Cash & Equiv.$2M$3.87B

WORX vs CAHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

WORX
CAH
StockMay 20May 26Return
SCWorx Corp. (WORX)1000.1-99.9%
Cardinal Health, In… (CAH)100352.7+252.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: WORX vs CAH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CAH leads in 6 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. As sector peers, any of these can serve as alternatives in the same allocation.
WORX
SCWorx Corp.
The Specific-Use Pick

In this particular matchup, WORX is outpaced on most metrics by others in the set.

Best for: healthcare exposure
CAH
Cardinal Health, Inc.
The Income Pick

CAH carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 20 yrs, beta 0.03, yield 1.1%
  • Rev growth -1.9%, EPS growth 87.0%, 3Y rev CAGR 7.1%
  • 160.8% 10Y total return vs WORX's -100.0%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthCAH logoCAH-1.9% revenue growth vs WORX's -3.7%
Quality / MarginsCAH logoCAH0.6% margin vs WORX's -154.4%
Stability / SafetyCAH logoCAHBeta 0.03 vs WORX's 1.77
DividendsCAH logoCAH1.1% yield; 20-year raise streak; the other pay no meaningful dividend
Momentum (1Y)CAH logoCAH+22.0% vs WORX's -91.2%
Efficiency (ROA)CAH logoCAH2.8% ROA vs WORX's -61.6%, ROIC 33.8% vs -14.5%

WORX vs CAH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

WORXSCWorx Corp.
FY 2017
Promotion Segment
71.7%$3M
Athlete Management
22.1%$934,043
Ticket Service Segment
5.2%$221,183
Corporate Segment
0.9%$36,330
CAHCardinal Health, Inc.
FY 2025
Pharmaceutical Member
91.9%$204.6B
GMPD
5.7%$12.6B
Other Operating Segment
2.4%$5.4B

WORX vs CAH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCAHLAGGINGWORX

Income & Cash Flow (Last 12 Months)

Evenly matched — WORX and CAH each lead in 3 of 6 comparable metrics.

CAH is the larger business by revenue, generating $250.5B annually — 87067.9x WORX's $3M. CAH is the more profitable business, keeping 0.6% of every revenue dollar as net income compared to WORX's -154.4%.

MetricWORX logoWORXSCWorx Corp.CAH logoCAHCardinal Health, …
RevenueTrailing 12 months$3M$250.5B
EBITDAEarnings before interest/tax$972,248$3.2B
Net IncomeAfter-tax profit-$4M$1.6B
Free Cash FlowCash after capex-$2M$4.4B
Gross MarginGross profit ÷ Revenue+32.0%+3.7%
Operating MarginEBIT ÷ Revenue-33.3%+0.9%
Net MarginNet income ÷ Revenue-154.4%+0.6%
FCF MarginFCF ÷ Revenue-54.0%+1.8%
Rev. Growth (YoY)Latest quarter vs prior year+13.8%+11.0%
EPS Growth (YoY)Latest quarter vs prior year+63.6%-19.5%
Evenly matched — WORX and CAH each lead in 3 of 6 comparable metrics.

Valuation Metrics

WORX leads this category, winning 2 of 2 comparable metrics.
MetricWORX logoWORXSCWorx Corp.CAH logoCAHCardinal Health, …
Market CapShares × price$202,035$43.6B
Enterprise ValueMkt cap + debt − cash-$1M$49.1B
Trailing P/EPrice ÷ TTM EPS-0.08x28.72x
Forward P/EPrice ÷ next-FY EPS est.17.94x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple16.01x
Price / SalesMarket cap ÷ Revenue0.07x0.20x
Price / BookPrice ÷ Book value/share0.05x
Price / FCFMarket cap ÷ FCF23.56x
WORX leads this category, winning 2 of 2 comparable metrics.

Profitability & Efficiency

CAH leads this category, winning 5 of 7 comparable metrics.

On the Piotroski fundamental quality scale (0–9), CAH scores 6/9 vs WORX's 4/9, reflecting solid financial health.

MetricWORX logoWORXSCWorx Corp.CAH logoCAHCardinal Health, …
ROE (TTM)Return on equity-73.5%
ROA (TTM)Return on assets-61.6%+2.8%
ROICReturn on invested capital-14.5%+33.8%
ROCEReturn on capital employed-16.4%+19.2%
Piotroski ScoreFundamental quality 0–946
Debt / EquityFinancial leverage0.00x
Net DebtTotal debt minus cash-$2M$5.5B
Cash & Equiv.Liquid assets$2M$3.9B
Total DebtShort + long-term debt$1,539$9.3B
Interest CoverageEBIT ÷ Interest expense-0.49x6.38x
CAH leads this category, winning 5 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

CAH leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CAH five years ago would be worth $33,568 today (with dividends reinvested), compared to $23 for WORX. Over the past 12 months, CAH leads with a +22.0% total return vs WORX's -91.2%. The 3-year compound annual growth rate (CAGR) favors CAH at 31.5% vs WORX's -76.9% — a key indicator of consistent wealth creation.

MetricWORX logoWORXSCWorx Corp.CAH logoCAHCardinal Health, …
YTD ReturnYear-to-date-75.8%-9.5%
1-Year ReturnPast 12 months-91.2%+22.0%
3-Year ReturnCumulative with dividends-98.8%+127.3%
5-Year ReturnCumulative with dividends-99.8%+235.7%
10-Year ReturnCumulative with dividends-100.0%+160.8%
CAGR (3Y)Annualised 3-year return-76.9%+31.5%
CAH leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

CAH leads this category, winning 2 of 2 comparable metrics.

CAH is the less volatile stock with a 0.03 beta — it tends to amplify market swings less than WORX's 1.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CAH currently trades 79.3% from its 52-week high vs WORX's 5.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricWORX logoWORXSCWorx Corp.CAH logoCAHCardinal Health, …
Beta (5Y)Sensitivity to S&P 5001.77x0.03x
52-Week HighHighest price in past year$13.05$233.60
52-Week LowLowest price in past year$0.20$137.75
% of 52W HighCurrent price vs 52-week peak+5.7%+79.3%
RSI (14)Momentum oscillator 0–10018.633.2
Avg Volume (50D)Average daily shares traded1.6M1.7M
CAH leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

CAH leads this category, winning 1 of 1 comparable metric.

CAH is the only dividend payer here at 1.10% yield — a key consideration for income-focused portfolios.

MetricWORX logoWORXSCWorx Corp.CAH logoCAHCardinal Health, …
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$249.67
# AnalystsCovering analysts33
Dividend YieldAnnual dividend ÷ price+1.1%
Dividend StreakConsecutive years of raises220
Dividend / ShareAnnual DPS$2.04
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.8%
CAH leads this category, winning 1 of 1 comparable metric.
Key Takeaway

CAH leads in 4 of 6 categories (Profitability & Efficiency, Total Returns). WORX leads in 1 (Valuation Metrics). 1 tied.

Best OverallCardinal Health, Inc. (CAH)Leads 4 of 6 categories
Loading custom metrics...

WORX vs CAH: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is WORX or CAH a better buy right now?

For growth investors, Cardinal Health, Inc.

(CAH) is the stronger pick with -1. 9% revenue growth year-over-year, versus -3. 7% for SCWorx Corp. (WORX). Cardinal Health, Inc. (CAH) offers the better valuation at 28. 7x trailing P/E (17. 9x forward), making it the more compelling value choice. Analysts rate Cardinal Health, Inc. (CAH) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — WORX or CAH?

Over the past 5 years, Cardinal Health, Inc.

(CAH) delivered a total return of +235. 7%, compared to -99. 8% for SCWorx Corp. (WORX). Over 10 years, the gap is even starker: CAH returned +160. 8% versus WORX's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — WORX or CAH?

By beta (market sensitivity over 5 years), Cardinal Health, Inc.

(CAH) is the lower-risk stock at 0. 03β versus SCWorx Corp. 's 1. 77β — meaning WORX is approximately 5124% more volatile than CAH relative to the S&P 500.

04

Which is growing faster — WORX or CAH?

By revenue growth (latest reported year), Cardinal Health, Inc.

(CAH) is pulling ahead at -1. 9% versus -3. 7% for SCWorx Corp. (WORX). On earnings-per-share growth, the picture is similar: Cardinal Health, Inc. grew EPS 87. 0% year-over-year, compared to 21. 8% for SCWorx Corp.. Over a 3-year CAGR, CAH leads at 7. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — WORX or CAH?

Cardinal Health, Inc.

(CAH) is the more profitable company, earning 0. 7% net margin versus -154. 4% for SCWorx Corp. — meaning it keeps 0. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CAH leads at 1. 0% versus -33. 3% for WORX. At the gross margin level — before operating expenses — WORX leads at 32. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — WORX or CAH?

In this comparison, CAH (1.

1% yield) pays a dividend. WORX does not pay a meaningful dividend and should not be held primarily for income.

07

Is WORX or CAH better for a retirement portfolio?

For long-horizon retirement investors, Cardinal Health, Inc.

(CAH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 03), 1. 1% yield, +160. 8% 10Y return). SCWorx Corp. (WORX) carries a higher beta of 1. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CAH: +160. 8%, WORX: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between WORX and CAH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

CAH pays a dividend while WORX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

WORX

Quality Business

  • Sector: Healthcare
  • Market Cap > $20B
  • Revenue Growth > 6%
  • Gross Margin > 19%
Run This Screen
Stocks Like

CAH

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform WORX and CAH on the metrics below

Revenue Growth>
%
(WORX: 13.8% · CAH: 11.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.